First pediatric B-acute lymphoblastic leukemia patient treated with anti-CD19 chimeric antigen receptor T-cell therapy: Long-term remission or early cure?

被引：2
作者：
Bouzianas, Dimitrios [1 ,3 ]
Bouziana, Stella [2 ]
机构：
[1] BReMeL Biopharmaceut & Regenerat Med Labs, Thessaloniki, Greece
[2] Kings Coll Hosp London, Dept Hematol, London, England
[3] BReMeL Biopharmaceut & Regenerat Med Labs, 4th Thermaikou str, Thessaloniki 55534, Greece
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2024年 / 20卷 / 01期
关键词：
CAR T-cells; tisagenlecleucel; B-acute lymphoblastic leukemia; immunotherapy; long-term remission; cure;
D O I：
10.1080/21645515.2024.2321678
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
[41]   Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy [J].
Zixun Yan ;
Li Li ;
Di Fu ;
Wen Wu ;
Niu Qiao ;
Yaohui Huang ;
Lu Jiang ;
Depei Wu ;
Yu Hu ;
Huilai Zhang ;
Pengpeng Xu ;
Shu Cheng ;
Li Wang ;
Sahin Lacin ;
Muharrem Muftuoglu ;
Weili Zhao .
Frontiers of Medicine, 2023, 17 (04) :699-713
[42]   Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy [J].
Zixun Yan ;
Li Li ;
Di Fu ;
Wen Wu ;
Niu Qiao ;
Yaohui Huang ;
Lu Jiang ;
Depei Wu ;
Yu Hu ;
Huilai Zhang ;
Pengpeng Xu ;
Shu Cheng ;
Li Wang ;
Sahin Lacin ;
Muharrem Muftuoglu ;
Weili Zhao .
Frontiers of Medicine, 2023, 17 :699-713
[43]   Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy [J].
Yan, Zixun ;
Li, Li ;
Fu, Di ;
Wu, Wen ;
Qiao, Niu ;
Huang, Yaohui ;
Jiang, Lu ;
Wu, Depei ;
Hu, Yu ;
Zhang, Huilai ;
Xu, Pengpeng ;
Cheng, Shu ;
Wang, Li ;
Lacin, Sahin ;
Muftuoglu, Muharrem ;
Zhao, Weili .
FRONTIERS OF MEDICINE, 2023, 17 (04) :699-713
[44]   The mechanisms of B-cell acute lymphoblastic leukemia relapsing following chimeric antigen receptor-T cell therapy; the plausible future strategies [J].
Karimi-Googheri, Masoud ;
Gholipourmalekabadi, Mazaher ;
Madjd, Zahra ;
Shabani, Ziba ;
Rostami, Zhila ;
Kazemi Arababadi, Mohammad ;
Kiani, Jafar .
MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
[45]   INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia [J].
Lamble, Adam J. ;
Moskop, Amy ;
Pulsipher, Michael A. ;
Maude, Shannon L. ;
Summers, Corinne ;
Annesley, Colleen ;
Baruchel, Andre ;
Gore, Lia ;
Amrolia, Persis ;
Shah, Nirali .
TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (11) :674-684
[46]   An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells [J].
Zhang, Yajing ;
Zhang, Wenying ;
Dai, Hanren ;
Wang, Yao ;
Shi, Fengxia ;
Wang, Chunmeng ;
Guo, Yelei ;
Liu, Yang ;
Chen, Meixia ;
Feng, Kaichao ;
Zhang, Yan ;
Liu, Chuanjie ;
Yang, Qingming ;
Li, Suxia ;
Han, Weidong .
SCIENCE CHINA-LIFE SCIENCES, 2016, 59 (04) :379-385
[47]   Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphoma [J].
Mihara, Keichiro ;
Yanagihara, Kazuyoshi ;
Takigahira, Misato ;
Kitanaka, Akira ;
Imai, Chihaya ;
Bhattacharyya, Joyeeta ;
Kubo, Takanori ;
Takei, Yoshifumi ;
Yasunaga, Shin'ichiro ;
Takihara, Yoshihiro ;
Kimura, Akiro .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (01) :37-46
[48]   CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL) [J].
Tasian, Sarah K. ;
Gardner, Rebecca A. .
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2015, 6 (05) :228-241
[49]   Anti-CD19 chimeric antigen receptor-modified T cells for B-cell malignancies: a systematic review of efficacy and safety in clinical trials [J].
Zhu, Yangmin ;
Tan, Youping ;
Ou, Ruiming ;
Zhong, Qi ;
Zheng, Liling ;
Du, Yuanyuan ;
Zhang, Qing ;
Huang, Jing .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (04) :389-396
[50]   Anti-CD19 chimeric antigen receptors T cells for the treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: report of three cases [J].
Zhang, Jian ;
Yang, Fei ;
Qiu, Hui-Ying ;
Wu, Qian ;
Kong, Dan-Qing ;
Zhou, Jin ;
Han, Yue ;
Wu, De-Pei .
LEUKEMIA & LYMPHOMA, 2019, 60 (06) :1454-1461
12345